Review of metformin's benefits for cardiovascular and brain health finds surprising reduct

Review of metformin's benefits for cardiovascular and brain health finds surprising reduction in prostate cancer. A drug commonly used to treat type 2 diabetes has the added bonus of reducing the risk of prostate cancer, new research has found.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: A drug commonly used to treat type 2 diabetes has the added bonus of reducing the risk of prostate cancer, new research has found. For the study, published in Rejuvenation Research, researchers conducted a literature review of research from the past 10 years, covering 2.25 million patients with type 2 diabetes taking metformin.

• Ponto de atenção: review.
• Ponto de atenção: metformin.
• Ponto de atenção: benefits.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.